Skip Navigation
Skip to contents

SICEM2026

Thyroid

Thyroid

Clinical update 1
From guidelines to practice: Evolving strategies in differentiated thyroid cancer
Day 2, Friday, April 10, 08:30-10:00 / Room 2(West tower B1F) Overview
Recent clinical guidelines reflect important changes in the treatment and long-term follow-up of differentiated thyroid cancer. Prof. Eun-Kyeong Lee will review the Korean Thyroid Association and the American Thyroid Association guidelines, highlighting key updates relevant to clinical practice. Prof. Yoon Young Cho will discuss TSH suppression strategies based on recent evidence. Prof. Sophie Leboulleux will present current trends and clinical applications of radioactive iodine therapy. This session will provide practical guidance for clinicians managing differentiated thyroid cancer.

Chairpersons : Ka Hee Yi (Seoul National University, Korea), Dong Yeob Shin (Yonsei University, Korea)

08:30-09:00 KTA vs. ATA guidelines: Endocrinologist’s perspectives Eun Kyung Lee (National Cancer Center, Korea)
09:00-09:30 Long-term follow-up strategies in differentiated thyroid cancer: Focus on TSH suppression Yoon Young Cho (Soon Chun Hyang University, Korea)
09:30-10:00 Recent trends and clinical applications of radioactive iodine therapy in thyroid cancer Sophie Leboulleux (University of Geneva, Switzerland)
Symposium 5
Evolving therapeutic strategies in advanced thyroid cancer
Day 2, Friday, April 10, 13:40-15:10 / Room 2(West tower B1F) Overview
In advanced thyroid cancer, individualized decisions on the timing and selection of systemic therapy, together with proactive management of treatment-related adverse events, are critical for optimizing clinical outcomes. This session reviews current therapeutic strategies based on recent clinical evidence. Prof. Won Gu Kim will present practical approaches to targeted therapy in advanced thyroid cancer, followed by Prof. Sun Min Lim’s overview of immune checkpoint inhibitors and combination therapies. Prof. Yoo Hyung Kim will discuss evidence-based strategies for the management of immune-related adverse events to support individualized treatment.

Chairpersons : Tae Yong Kim (University of Ulsan, Korea), Sun Wook Cho (Seoul National University, Korea)

13:40-14:10 Optimizing targeted therapy for treatment of radioiodine-refractory thyroid cancer Won Gu Kim (University of Ulsan, Korea)
14:10-14:40 Immune checkpoint inhibitors and combination therapy in thyroid cancer Sun Min Lim (Yonsei University, Korea)
14:40-15:10 Immune-related adverse events: From mechanistic insights to management Yoo Hyung Kim (Seoul National University, Korea)
Hot topic
Hot topics in thyroid diseases
Day 2, Friday, April 10, 16:10-17:40 / Room 2(West tower B1F) Overview
Research in thyroid diseases is rapidly advancing, calling for integrative approaches that bridge molecular mechanisms, epidemiology, and precision medicine.This session will explore emerging frontiers in thyroidology. Prof. Hyemi Kwon will address clinical and translational perspectives on the cross-talk between thyroid hormones and organ systems. Prof. Kosuke Inoue will discuss applications of causal inference and machine learning in thyroid epidemiology, and Prof. Carmelo Nucera will present novel biomarkers that enable precision medicine in thyroid cancer.

Chairpersons : Sun Wook Kim (Sungkyunkwan University, Korea), Hee-Kyung Kim(Chonnam National University, Korea)

16:10-16:40 Thyroid cancer and the metabolic landscape: Clinical and translational perspectives Hyemi Kwon (Sungkyunkwan University, Korea)
16:40-17:10 Causal inference and modern statistical approach in thyroid epidemiology Kosuke Inoue (Kyoto University, Japan)
17:10-17:40 Molecular drivers in thyroid cancer Carmelo Nucera (Beth Israel Deaconess Medical Center, Harvard Medical School, USA)
Symposium 12
Up to dated approach for thyroid dysfunction
Day 3, Saturday, April 11, 14:50-16:20 / Room 2(West tower B1F) Overview
This session introduces various approaches to evaluating and managing thyroid dysfunction based on recent advances in technology and emerging clinical evidence. Prof. Won Sang Yoo will discuss the application of artificial intelligence to the management and clinical decision-making processes in thyroid dysfunction. Prof. Chun Jui Huang will review the latest research evidence regarding thyroid disorders during pregnancy. Prof. Hansang Baek will present recent trends in the use of ultrasonography and its practical applications for patients with thyroid dysfunction. This session will offer an updated understanding of current developments and evolving perspectives in the management of thyroid dysfunction.

Chairpersons : EunSook Kim (University of Ulsan, Korea), Tae Hyuk Kim (Sungkyunkwan University, Korea)

14:50-15:20 The AI horizon in thyroidology Wonsang Yoo (Dankook University, Korea)
15:20-15:50 Updates regarding thyroid function and iodine nutrition in pregnancy Chun-Jui Huang (Taipei Veterans General Hospital, Taiwan)
15:50-16:20 Updates in ultrasonography for benign thyroid diseases: Beyond thyroid nodules Han-Sang Baek (The Catholic University of Korea, Korea)
Korean Endocrine Society
101-2503, Lotte Castle President, 109, Mapo-daero, Mapo-gu, Seoul 04146, Republic of Korea
T. +82-2-714-2428   |  E. endo@endocrinology.or.kr  |  W. www.endocrinology.or.kr
Business Registration Number: 106-82-31113  |  Name of Representative : Eun-Gyoung Hong
SICEM 2026 Secretariat (INTO-ON)
4F, A-Block, Richensia, 341, Baekbeom-ro, Yongsan-gu, Seoul 04315, Republic of Korea
T. +82-2-2285-2582  |  E. sicem2026@into-on.com  |   W. www.into-on.com
  • 전체 방문자 수 : 83319 명
  • 금일 방문자 수 : 752 명

Copyright ⓒ The Korean Endocrine Society. All rights Reserved